Trupanion Inc (TRUP) Director Howard E. Rubin Sells 75,000 Shares of Stock
Trupanion Inc (NYSE:TRUP) Director Howard E. Rubin sold 75,000 shares of the firm’s stock in a transaction dated Monday, October 3rd. The stock was sold at an average price of $16.56, for a total value of $1,242,000.00. Following the sale, the director now directly owns 100,000 shares of the company’s stock, valued at $1,656,000. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Trupanion Inc (NYSE:TRUP) opened at 15.98 on Thursday. The stock’s market cap is $463.66 million. The stock has a 50 day moving average price of $15.82 and a 200 day moving average price of $13.95. Trupanion Inc has a 52 week low of $6.27 and a 52 week high of $17.68.
Trupanion (NYSE:TRUP) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.06. The company earned $45.83 million during the quarter, compared to analysts’ expectations of $45.05 million. During the same quarter in the prior year, the company earned ($0.17) earnings per share. The firm’s revenue was up 28.8% compared to the same quarter last year. On average, equities analysts predict that Trupanion Inc will post ($0.22) earnings per share for the current year.
TRUP has been the subject of a number of recent analyst reports. Lake Street Capital initiated coverage on Trupanion in a research report on Tuesday, July 19th. They set a “buy” rating and a $18.00 price objective for the company. Zacks Investment Research downgraded Trupanion from a “buy” rating to a “hold” rating in a research report on Wednesday, July 27th. RBC Capital Markets reissued an “outperform” rating and set a $18.00 price objective (up from $14.00) on shares of Trupanion in a research report on Wednesday, August 3rd. Canaccord Genuity reissued a “buy” rating and set a $19.00 price objective on shares of Trupanion in a research report on Thursday, August 4th. Finally, Stifel Nicolaus raised their target price on Trupanion from $17.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, August 3rd. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $15.75.
A number of institutional investors have recently added to or reduced their stakes in the stock. AQR Capital Management LLC acquired a new position in Trupanion during the second quarter valued at approximately $146,000. Metropolitan Life Insurance Co. NY acquired a new position in Trupanion during the second quarter valued at approximately $160,000. A.R.T. Advisors LLC acquired a new position in Trupanion during the second quarter valued at approximately $166,000. Alliancebernstein L.P. acquired a new position in Trupanion during the second quarter valued at approximately $168,000. Finally, Thompson Davis & CO. Inc. acquired a new position in Trupanion during the second quarter valued at approximately $181,000.
Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.
Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.